Abstract
The aim of this meta-analysis was to compare the effects of LRYGB and LSG on dyslipidemia. Studies comparing the effects of LRYGB and LSG on dyslipidemia with follow-up of 12 months or more were included. Twenty-four studies comprising seven RCTs and 17 comparative observational studies were included. Meta-analysis of RCTs (n=487) showed that improvement/resolution of dyslipidemia was better after LRYGB (68.5%, n=161/235) compared to LSG (48.4%, n=122/252). Patients undergoing LRYGB were more than twice as likely to experience improvement/resolution in dyslipidemia compared to those undergoing LSG (OR 2.28, 95% CI 1.21–4.29, p=0.010). Both LRGYB and LSG appears effective in improving dyslipidemia at >12 months after surgery; however, this improvement is more than twice higher after LRYGB compared to LSG.
Similar content being viewed by others
References
Schilling PL, Davis MM, Albanese CT, et al. National trends in adolescent bariatric surgical procedures and implications for surgical centers of excellence. J Am Coll Surg [Internet]. 2008;206:1–12. http://www.ncbi.nlm.nih.gov/pubmed/18155562
Tzotzas T, Evangelou P, Kiortsis DN. Obesity, weight loss and conditional cardiovascular risk factors. Obes Rev [Internet]. 2011;12:e282–9. http://www.ncbi.nlm.nih.gov/pubmed/21054756
Schauer PR, Kashyap SR, Wolski K, et al. Bariatric surgery versus intensive medical therapy in obese patients with diabetes. N Engl J Med [Internet]. 2012;366:1567–76. http://www.ncbi.nlm.nih.gov/pubmed/22449319
Cook CM, Edwards C. Success habits of long-term gastric bypass patients. Obes Surg [Internet]. 1999;9:80–2. http://www.ncbi.nlm.nih.gov/pubmed/10065592
Li C, Ford ES, Zhao G, et al. Prevalence of self-reported clinically diagnosed sleep apnea according to obesity status in men and women: National Health and Nutrition Examination Survey, 2005-2006. Prev Med (Baltim) [Internet]. 2010;51:18–23. http://www.ncbi.nlm.nih.gov/pubmed/20381517
Schauer PR, Bhatt DL, Kirwan JP, et al. Bariatric surgery versus intensive medical therapy for diabetes--3-year outcomes. N Engl J Med [Internet]. 2014;370:2002–13. http://www.ncbi.nlm.nih.gov/pubmed/24679060
Schauer PR, Bhatt DL, Kirwan JP, et al. Bariatric surgery versus intensive medical therapy for diabetes - 5-year outcomes. N Engl J Med [Internet]. 2017;376:641–51. http://www.ncbi.nlm.nih.gov/pubmed/28199805
Milone M, Di Minno MND, Leongito M, et al. Bariatric surgery and diabetes remission: sleeve gastrectomy or mini-gastric bypass? World J Gastroenterol [Internet]. 2013;19:6590–7. http://www.ncbi.nlm.nih.gov/pubmed/24151386
Lee W-J, Chong K, Ser K-H, et al. Gastric bypass vs sleeve gastrectomy for type 2 diabetes mellitus: a randomized controlled trial. Arch Surg [Internet]. 2011;146:143–8. http://www.ncbi.nlm.nih.gov/pubmed/21339423
Sjöström L, Lindroos A-K, Peltonen M, et al. Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery. N Engl J Med [Internet]. 2004;351:2683–93. http://www.ncbi.nlm.nih.gov/pubmed/15616203
Dhabuwala A, Cannan RJ, Stubbs RS. Improvement in co-morbidities following weight loss from gastric bypass surgery. Obes Surg [Internet]. 2000;10:428–35. http://www.ncbi.nlm.nih.gov/pubmed/11054247
Nguyen NT, Varela E, Sabio A, et al. Resolution of hyperlipidemia after laparoscopic Roux-en-Y gastric bypass. J Am Coll Surg [Internet]. 2006;203:24–9. http://www.ncbi.nlm.nih.gov/pubmed/16798484
Habib P, Scrocco JD, Terek M, et al. Effects of bariatric surgery on inflammatory, functional and structural markers of coronary atherosclerosis. Am J Cardiol [Internet]. 2009;104:1251–5. http://www.ncbi.nlm.nih.gov/pubmed/19840571
Asztalos BF, Swarbrick MM, Schaefer EJ, et al. Effects of weight loss, induced by gastric bypass surgery, on HDL remodeling in obese women. J Lipid Res [Internet]. 2010;51:2405–12. http://www.ncbi.nlm.nih.gov/pubmed/20631298
Pihlajamäki J, Grönlund S, Simonen M, et al. Cholesterol absorption decreases after Roux-en-Y gastric bypass but not after gastric banding. Metabolism [Internet]. 2010;59:866–72. http://www.ncbi.nlm.nih.gov/pubmed/20015521
Karamanakos SN, Vagenas K, Kalfarentzos F, et al. Weight loss, appetite suppression, and changes in fasting and postprandial ghrelin and peptide-YY levels after Roux-en-Y gastric bypass and sleeve gastrectomy: a prospective, double blind study. Ann Surg [Internet]. 2008;247:401–7. http://www.ncbi.nlm.nih.gov/pubmed/18376181
Vix M, Diana M, Liu K-H, et al. Evolution of glycolipid profile after sleeve gastrectomy vs. Roux-en-Y gastric bypass: results of a prospective randomized clinical trial. Obes Surg [Internet]. 2013;23:613–21. http://www.ncbi.nlm.nih.gov/pubmed/23207829
Moher D, Liberati A, Tetzlaff J, et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ [Internet]. 2009;339:b2535. http://www.ncbi.nlm.nih.gov/pubmed/19622551
Kasama K, Tagaya N, Kanahira E, et al. Has laparoscopic bariatric surgery been accepted in Japan? The experience of a single surgeon. Obes Surg [Internet]. 2008;18:1473–8. http://www.ncbi.nlm.nih.gov/pubmed/18398667
Vidal P, Ramón JM, Goday A, et al. Laparoscopic gastric bypass versus laparoscopic sleeve gastrectomy as a definitive surgical procedure for morbid obesity. Mid-term results. Obes Surg [Internet]. 2013;23:292–9. http://www.ncbi.nlm.nih.gov/pubmed/23196992
Thereaux J, Corigliano N, Poitou C, et al. Comparison of results after one year between sleeve gastrectomy and gastric bypass in patients with BMI ≥ 50 kg/m2. Surg Obes Relat Dis [Internet]. 11:785–90. http://www.ncbi.nlm.nih.gov/pubmed/25771441
Zhang N, Maffei A, Cerabona T, et al. Reduction in obesity-related obseity associated medical conditions: is gastric bypass better than sleeve gastrectomy? Surg Endosc [Internet]. 2013;27:1273–80. http://www.ncbi.nlm.nih.gov/pubmed/23239292
Yang J, Wang C, Cao G, et al. Long-term effects of laparoscopic sleeve gastrectomy versus roux-en-Y gastric bypass for the treatment of Chinese type 2 diabetes mellitus patients with body mass index 28-35 kg/m(2). BMC Surg [Internet]. 2015;15:88. http://www.ncbi.nlm.nih.gov/pubmed/26198306
Jammu GS, Sharma R. A 7-year clinical audit of 1107 cases comparing sleeve gastrectomy, Roux-En-Y gastric bypass, and mini-gastric bypass, to determine an effective and safe bariatric and metabolic procedure. Obes Surg [Internet]. 2016;26:926–32. http://www.ncbi.nlm.nih.gov/pubmed/26337694
Perrone F, Bianciardi E, Ippoliti S, et al. Long-term effects of laparoscopic sleeve gastrectomy versus Roux-en-Y gastric bypass for the treatment of morbid obesity: a monocentric prospective study with minimum follow-up of 5 years. Updates Surg [Internet]. 2017;69:101–7. http://www.ncbi.nlm.nih.gov/pubmed/28266000
Uno K, Seki Y, Kasama K, et al. A Comparison of the bariatric procedures that are performed in the treatment of super morbid obesity. Obes Surg [Internet]. 2017;27:2537–45. http://www.ncbi.nlm.nih.gov/pubmed/28451928
Ahmed B, King WC, Gourash W, et al. Long-term weight change and health outcomes for sleeve gastrectomy (SG) and matched Roux-en-Y gastric bypass (RYGB) participants in the longitudinal assessment of bariatric surgery (LABS) study. Surgery [Internet]. 2018;164:774–83. http://www.ncbi.nlm.nih.gov/pubmed/30139560
Salminen P, Helmiö M, Ovaska J, et al. Effect of laparoscopic sleeve gastrectomy vs laparoscopic Roux-en-Y gastric bypass on weight loss at 5 years among patients with morbid obesity: the SLEEVEPASS randomized clinical trial. JAMA [Internet]. 2018;319:241–54. http://www.ncbi.nlm.nih.gov/pubmed/29340676
Peterli R, Wölnerhanssen BK, Peters T, et al. Effect of laparoscopic sleeve gastrectomy vs laparoscopic Roux-en-Y gastric bypass on weight loss in patients with morbid obesity: the SM-BOSS randomized clinical trial. JAMA [Internet]. 2018;319:255–65. http://www.ncbi.nlm.nih.gov/pubmed/29340679
Abbatini F, Rizzello M, Casella G, et al. Long-term effects of laparoscopic sleeve gastrectomy, gastric bypass, and adjustable gastric banding on type 2 diabetes. Surg Endosc [Internet]. 2010;24:1005–10. http://www.ncbi.nlm.nih.gov/pubmed/19866235
Bettencourt-Silva R, Neves JS, Pedro J, et al. Comparative effectiveness of different bariatric procedures in super morbid obesity. Obes Surg [Internet]. 2019;29:281–91. http://www.ncbi.nlm.nih.gov/pubmed/30251091
Ruiz-Tovar J, Carbajo MA, Jimenez JM, et al. Long-term follow-up after sleeve gastrectomy versus Roux-en-Y gastric bypass versus one-anastomosis gastric bypass: a prospective randomized comparative study of weight loss and remission of obseity associated medical conditions. Surg Endosc [Internet]. 2019;33:401–10. http://www.ncbi.nlm.nih.gov/pubmed/29943058
Benaiges D, Goday A, Ramon JM, et al. Laparoscopic sleeve gastrectomy and laparoscopic gastric bypass are equally effective for reduction of cardiovascular risk in severely obese patients at one year of follow-up. Surg Obes Relat Dis [Internet]. 7:575–80. http://www.ncbi.nlm.nih.gov/pubmed/21546321
Iannelli A, Anty R, Schneck AS. Inflammation, insulin resistance, lipid disturbances, anthropometrics, and metabolic syndrome in morbidly obese patients: a case control study comparing laparoscopic Roux-en-Y gastric bypass and laparoscopic sleeve gastrectomy. Surgery [Internet]. 2011;149:364–70. http://www.ncbi.nlm.nih.gov/pubmed/20932542
Kehagias I, Karamanakos SN, Argentou M, et al. Randomized clinical trial of laparoscopic Roux-en-Y gastric bypass versus laparoscopic sleeve gastrectomy for the management of patients with BMI < 50 kg/m2. Obes Surg [Internet]. 2011;21:1650–6. http://www.ncbi.nlm.nih.gov/pubmed/21818647
Boza C, Gamboa C, Salinas J. Laparoscopic Roux-en-Y gastric bypass versus laparoscopic sleeve gastrectomy: a case-control study and 3 years of follow-up. Surg Obes Relat Dis [Internet]. 8:243–9. http://www.ncbi.nlm.nih.gov/pubmed/22285881
Zhang Y, Zhao H, Cao Z, et al. A randomized clinical trial of laparoscopic Roux-en-Y gastric bypass and sleeve gastrectomy for the treatment of morbid obesity in China: a 5-year outcome. Obes Surg [Internet]. 2014;24:1617–24. http://www.ncbi.nlm.nih.gov/pubmed/24827405
Cutolo PP, Nosso G, Vitolo G, et al. Clinical efficacy of laparoscopic sleeve gastrectomy vs laparoscopic gastric bypass in obese type 2 diabetic patients: a retrospective comparison. Obes Surg [Internet]. 2012;22:1535–9. http://www.ncbi.nlm.nih.gov/pubmed/22960950
Carlin AM, Zeni TM, English WJ, et al. The comparative effectiveness of sleeve gastrectomy, gastric bypass, and adjustable gastric banding procedures for the treatment of morbid obesity. Ann Surg [Internet]. 2013;257:791–7. http://www.ncbi.nlm.nih.gov/pubmed/23470577
Sjöström L, Narbro K, Sjöström CD, et al. Effects of bariatric surgery on mortality in Swedish obese subjects. N Engl J Med [Internet]. 2007;357:741–52. http://www.ncbi.nlm.nih.gov/pubmed/17715408
Spivak H, Sakran N, Dicker D, et al. Different effects of bariatric surgical procedures on dyslipidemia: a registry-based analysis. Surg Obes Relat Dis [Internet]. 2017;13:1189–94. http://www.ncbi.nlm.nih.gov/pubmed/28456511
Cunha FM, Oliveira J, Preto J, et al. The effect of bariatric surgery type on lipid profile: an age, sex, body mass index and excess weight loss matched study. Obes Surg [Internet]. 2016;26:1041–7. http://www.ncbi.nlm.nih.gov/pubmed/26220239
Ito C, Mason EE. Gastric bypass and pancreatic secretion. Surgery [Internet]. 1971;69:526–32. http://www.ncbi.nlm.nih.gov/pubmed/5553917
Carswell KA, Belgaumkar AP, Amiel SA, et al. A systematic review and meta-analysis of the effect of gastric bypass surgery on plasma lipid levels. Obes Surg [Internet]. 2016;26:843–55. http://www.ncbi.nlm.nih.gov/pubmed/26210195
Tourky M, Issa M, Salman MA, et al. Nutritional complications after laparoscopic Roux-en-Y gastric bypass and one-anastomosis gastric bypass: a comparative systematic review and meta-analysis. Cureus [Internet]. 2022;14:e21114. http://www.ncbi.nlm.nih.gov/pubmed/35036236
Iannelli A, Anty R, Schneck AS, et al. Evolution of low-grade systemic inflammation, insulin resistance, anthropometrics, resting energy expenditure and metabolic syndrome after bariatric surgery: a comparative study between gastric bypass and sleeve gastrectomy. J Visc Surg [Internet]. 2013;150:269–75. http://www.ncbi.nlm.nih.gov/pubmed/24016714
Viana EC, Araujo-Dasilio KL, Miguel GPS, et al. Gastric bypass and sleeve gastrectomy: the same impact on IL-6 and TNF-α. Prospective clinical trial. Obes Surg [Internet]. 2013;23:1252–61. http://www.ncbi.nlm.nih.gov/pubmed/23475776
Author information
Authors and Affiliations
Contributions
All authors contributed to the data collection, analysis, and write-up of the study.
Corresponding author
Ethics declarations
Ethical Approval
For this type of study, formal consent is not required.
Informed Consent
Informed consent does not apply.
Conflict of Interest
The authors declare no competing interests.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Key Points
1. The meta-analysis compared the effects of LRYGB and LSG on dyslipidemia with a focus on outcomes after 12 months or more.
2. Results revealed that LRYGB had a significantly higher rate of improvement/resolution of dyslipidemia (68.5%) compared to LSG (48.4%).
3. The odds of experiencing improvement/resolution in dyslipidemia were more than twice as high for patients undergoing LRYGB (OR 2.28, 95% CI 1.21–4.29, p=0.010) compared to LSG, indicating the superiority of LRYGB in this context.
Appendix
Appendix
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Adil, M.T., Perera, M., Whitelaw, D. et al. Systematic Review and Meta-analysis of the Effects of Laparoscopic Roux-en-Y Gastric Bypass and Laparoscopic Sleeve Gastrectomy on Dyslipidemia. OBES SURG 34, 967–975 (2024). https://doi.org/10.1007/s11695-023-07022-2
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11695-023-07022-2